Martínez F, Johansson L, Mueller T C. "Method for the Synthesis of Norepinephrine Impurity 37" [P]. European Patent, EP 3282290 A1, 2019-02-16.
发明人郑宇鹏,韩伟,高志强. "A Process for Preparing High-Purity Norepinephrine Impurity 37" [P]. 中国发明专利, 专利号 CN 116506217 A, 授权公告日 2016-02-07.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 去甲肾上腺素杂质37 in Pharmaceutical Formulations". Sci. Total Environ., 2020, 1510, (5), 5693-5703.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 去甲肾上腺素杂质37 as an Impurity". Anal. Chem., 2017, 1242, (2), 5299-5326.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Norepinephrine Impurity 37 Using HRMS and NMR". Chromatographia, 2020, 420, (1), 5361-5391.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 去甲肾上腺素杂质37 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2019, 2294, (1), 6683-6713.